[ 7 ] reported that treatment with TTR stabilizers in asymptomatic patients with ATTR-CM was associated with improved long-term survival, with a favorable trend toward reducing or delaying the development of clinical HF.
← all excerpts
Navigating the emerging landscape of asymptomatic ATTR-CM: challenges, opportunities and the path ahead.
1
—
—